Furosemide NDC 17856-3298

NDC codes

FDA NDC Directory

Product NDC (as listed)17856-3298Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17856-3298Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
17856-3298-1	17856329801	5 mL in 1 CUP (17856-3298-1)Marketed from May 10, 2016

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Furosemide
Generic name (nonproprietary): furosemide
Active ingredients: Furosemide — 40 mg/5mL
Dosage form: Solution
Route: Oral
Labeler: Atlantic Biologicals Corps
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070433
Marketing start: Apr 22, 1987
Listing expires: Dec 31, 2027
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 17856-3298_5460bc4c-f415-0813-e063-6294a90a3091SPL ID 5460bc4c-f415-0813-e063-6294a90a3091SPL set ID 9c342198-7162-4cc5-bda1-bc4054a4292bRxCUI 197731UNII 7LXU5N7ZO5
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417856329801 followed by a unit qualifier and the quantity

Package 17856-3298-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 16, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Edema Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide alone.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 070433

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070433
Product	Strength	Form · route	Labeler	Product NDC
Furosemide	Furosemide 40 mg/5mL	SolutionOral	Hikma Pharmaceuticals USA Inc.	0054-3298
Furosemide	Furosemide 40 mg/5mL	SolutionOral	Precision Dose Inc.	68094-867